[a
]A
∗STAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and
Research (A
∗STAR), Singapore, Singapore
[b
]Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A
∗STAR), Singapore, Singapore
[c
]Bioinformatics Institute (BII), Agency of Science, Technology and Research (A
∗STAR), Singapore, Singapore
[d
]GISAID Global Data Science Initiative (GISAID), Munich, Germany
[e
]National Centre for Infectious Diseases, Singapore, Singapore
[f
]Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore
[g
]Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
[h
]National Public Health Laboratory, Singapore, Singapore
[i
]Department of Biological Sciences, National University of Singapore, Singapore, Singapore
[j
]Human Potential Translational Research Programme, Yong Loo Lin School of Medicine,
National University of Singapore, Singapore, Singapore
[k
]Saw Swee Hock School of Public Health, National University of Singapore, Singapore,
Singapore
[l
]Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore,
Singapore, Singapore
[m
]Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National
University of Singapore, Singapore, Singapore
[n
]National Institute of Health Research, Health Protection Research Unit in Emerging
and Zoonotic Infections, University of Liverpool, Liverpool, UK
[o
]Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool,
Liverpool, UK
[p
]School of Biological Sciences, Nanyang Technological University, Singapore, Singapore
[∗
]Corresponding author. Lisa F.P. Ng, A∗STAR ID Labs, A∗STAR, 8A Biomedical Grove, Immunos
#05-13, Singapore 138648, Singapore.
[∗∗
]Corresponding author. Laurent Renia, A∗STAR ID Labs, A∗STAR, 8A Biomedical Grove,
Immunos #05-13, Singapore 138648, Singapore.
[r]
These authors contributed equally to this work.
License:
Since January 2020 Elsevier has created a COVID-19 resource centre with free information
in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre
is hosted on Elsevier Connect, the company's public news and information website.
Elsevier hereby grants permission to make all its COVID-19-related research that is
available on the COVID-19 resource centre - including this research content - immediately
available in PubMed Central and other publicly funded repositories, such as the WHO
COVID database with rights for unrestricted research re-use and analyses in any form
or by any means with acknowledgement of the original source. These permissions are
granted for free by Elsevier for as long as the COVID-19 resource centre remains active.